Finch Therapeutics Group Inc (FNCH) Stock is looking to regain its victory

H.C. Wainwright raised the price target for the Finch Therapeutics Group Inc (NASDAQ:FNCH) stock to “a Buy”. The rating was released on August 09, 2022, according to finviz. The research report from Evercore ISI has initiated the stock to Outperform, with a price target set at $34. The stock was initiated by BofA Securities, who […]